Associated tags: Research, Element, SAN, Doctor of Philosophy, Genomics, Science, SVP, Fine chemical
Locations: FL, WASHINGTON, UNITED STATES, ASIA, EUROPE, ARIZONA, MEXICO, GERMANY, FRANCE, RARE, CALIFORNIA, NEW YORK, CA, RANCHO PALOS VERDES
Biology,
News,
Science,
SVP,
Element,
SAN,
Conference,
Research,
Growth,
Genome,
Workflow SAN DIEGO, May 14, 2024 /PRNewswire/ -- Element Biosciences, Inc., developer of pioneering technologies to empower science, today announced record growth in installations of its AVITI™ System ahead of its participation in upcoming investor conferences.
Key Points:
- SAN DIEGO, May 14, 2024 /PRNewswire/ -- Element Biosciences, Inc., developer of pioneering technologies to empower science, today announced record growth in installations of its AVITI™ System ahead of its participation in upcoming investor conferences.
- Element has now received more than 200 cumulative orders of AVITI – the sequencer that provides the highest quality sequencing on a benchtop for as low as $200 per genome.
- In just one year, the company's installed base has grown from more than 20 units to more than 150.
- "AVITI as our first product is now being used across the world to expand scientific possibilities, driving unprecedented growth for Element.
MAPK,
Today,
Science,
SAN,
DSM-IV codes,
Neoplasm,
Research,
RNA,
DNA,
Element,
Cancer,
Neuroscience,
Doctor of Philosophy,
Protein,
AACR,
Drug development,
Phosphoprotein,
Annual general meeting,
Vaccine SAN DIEGO, April 5, 2024 /PRNewswire/ -- Element Biosciences, Inc., developer of pioneering technologies to empower science, has begun taking orders for AVITI24™ the first instrument to combine state-of-the-art sequencing and cyto-profiling (mapping cell characteristics) into a single integrated biology platform, the company announced at the Annual Meeting of the American Association for Cancer Research.
Key Points:
- AVITI24 revolutionizes research by enabling simultaneous examination of DNA, RNA, proteins, phosphoproteins, and cell structure within single cells.
- Powered by Element's new Teton™ chemistry, AVITI24 expands on AVITI's best-in-class sequencing capabilities to offer new multi-omics functionality, simplifying results in one multi-omic read-out in less than 24 hours.
- This technology is particularly relevant for cancer researchers, facilitating in-depth exploration of the links between the molecular makeup of cancer cells and how they function within complex tumors.
- "Today, we are redefining what a sequencer can do by streamlining multiple conventional stages of discovery into a single powerful platform," said Molly He, PhD, CEO and co-founder of Element Biosciences.
SAN DIEGO, March 12, 2024 /PRNewswire/ -- Element Biosciences, Inc., developer of pioneering technologies to empower science, today announced the appointment of Danae Van Oene as Senior Vice President of Global Sales and Support.
Key Points:
- Element welcomes Danae Van Oene, a proven genomics commercial leader, as the company expands its multi-omics capabilities
SAN DIEGO, March 12, 2024 /PRNewswire/ -- Element Biosciences, Inc., developer of pioneering technologies to empower science, today announced the appointment of Danae Van Oene as Senior Vice President of Global Sales and Support.
- As Element expands its global customer base, she will work with Element customers and distributors internationally to maximize operational excellence and translate feedback into product innovations.
- Danae was most recently 10x Genomics' Vice President and General Manager for the Americas region after previously leading its global sales programs, global distribution, and strategic partnerships.
- Before joining 10x Genomics, she held global sales management roles at Illumina and was Distribution Territory Manager for Beckman Coulter.
Retrieved on:
Wednesday, February 28, 2024
Paper,
Molly,
SAN,
Doctor of Philosophy,
SVP,
Female,
Venrock,
COVID,
Genome,
CNBC,
Science,
Research,
Management As a first-generation Asian female leader, Molly was honored by CNBC for spearheading a remarkable undertaking to democratize sequencing and biological tools globally.
Key Points:
- As a first-generation Asian female leader, Molly was honored by CNBC for spearheading a remarkable undertaking to democratize sequencing and biological tools globally.
- Her work is a reflection of her commitment to collaborative science through fairness and accessibility for the research community.
- "Today is a great honor and a true testament to the journey the Element team has embarked on together since the company's founding," Molly He said.
- "We are incredibly proud to see Molly recognized on CNBC's inaugural Changemakers list," said Bryan Roberts, PhD, partner at Venrock and member of the Element Biosciences Board of Directors.
Retrieved on:
Wednesday, February 7, 2024
Partnership,
Labs,
SAN,
Science,
Corporation,
SVP,
Genomics,
Doctor of Philosophy,
Element,
Library,
Business,
Callisto,
Fine chemical "The work done by Element to broaden access to affordable, high-quality sequencing is unprecedented," said Udayan Umapathi, CEO at Volta Labs.
Key Points:
- "The work done by Element to broaden access to affordable, high-quality sequencing is unprecedented," said Udayan Umapathi, CEO at Volta Labs.
- "With this partnership, we will join forces with the Element team to offer an end-to-end solution to break the sample prep bottleneck and support sequencing at scale."
- This collaboration expands the reach of Volta's novel sample prep system, providing labs the flexibility to sequence smaller batches of reactions more frequently and at a lower cost.
- The Callisto Sample Prep System supports up to 24 reactions per run across at least eight applications, prepped for sequencing in hours.
Retrieved on:
Tuesday, February 6, 2024
Research,
General Health,
Biometrics,
Technology,
Genetics,
Health Technology,
Public Relations,
Investor Relations,
Science,
Nanotechnology,
Biotechnology,
Communications,
Health,
Other Science,
Multimedia,
Twist Bioscience,
Workflow,
Doctor of Philosophy,
Exome,
Learning,
Silicon,
NGS,
Element,
Fine chemical Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Element Biosciences, Inc. , developer of pioneering technologies to empower science, today announced a collaboration to develop the Twist for Element, Exome 2.0 plus Comprehensive Exome Spike-in Workflow for Element’s AVITI™ System.
Key Points:
- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Element Biosciences, Inc. , developer of pioneering technologies to empower science, today announced a collaboration to develop the Twist for Element, Exome 2.0 plus Comprehensive Exome Spike-in Workflow for Element’s AVITI™ System.
- View the full release here: https://www.businesswire.com/news/home/20240206284355/en/
“Element continues to expand its customer base, bringing high quality and cost-effective sequencing to researchers globally.
- Pairing Twist’s robust NGS workflows with Element’s AVITI technology will offer customers an economical and streamlined approach to next generation sequencing,” said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience.
- If interested in learning more about the Twist for Element, Exome 2.0 plus Comprehensive Exome Spike-in Workflow, please reach out here .
Retrieved on:
Tuesday, February 6, 2024
Cloud,
Transfer,
SAN,
Science,
Research,
Ecosystem,
FASTQ,
SVP,
DNAnexus,
Doctor of Philosophy,
Element SAN DIEGO, Feb. 6, 2024 /PRNewswire/ -- Element Biosciences, Inc., developer of pioneering technologies to empower science, announced a collaboration with DNAnexus, provider of the Precision Health Data Cloud, to allow customers to stream data from Element's AVITI™ System directly to their DNAnexus account. The collaboration combines the unmatched performance of AVITI sequencing with the secure and full-featured multi-omic analysis platform of DNAnexus. The integration of AVITI with DNAnexus will be available to customers in Q1 2024.
Key Points:
- The collaboration combines the unmatched performance of AVITI sequencing with the secure and full-featured multi-omic analysis platform of DNAnexus.
- "We are thrilled to have DNAnexus as a partner in the growing Element Biosciences analysis ecosystem," said Francisco Garcia, PhD, SVP of Informatics at Element Biosciences, speaking at the Advances in Genome Biology and Technology (AGBT) 2024 conference.
- "This collaboration provides our customers with direct integration to DNAnexus' robust, flexible and user-friendly multi-modal analysis platform."
- "Element Biosciences has established itself as a leading sequencing technology innovator and we are proud to join forces to help streamline multi-omics research."
Health,
Genetics,
Other Science,
Research,
Science,
Biotechnology,
Partnership,
Multimedia,
Senior,
RNA,
IDT,
DNA,
Commercial,
Corporation,
NGS,
PCR,
Doctor of Philosophy,
Business,
Integration,
Fine chemical Life sciences companies Integrated DNA Technologies (IDT) and Element Biosciences, Inc. have bolstered their partnership with products to enable more efficient and streamlined next generation sequencing (NGS) workflows for users of the AVITI System, an innovative sequencing and multi-omics platform based on Element’s novel avidity base chemistry.
Key Points:
- Life sciences companies Integrated DNA Technologies (IDT) and Element Biosciences, Inc. have bolstered their partnership with products to enable more efficient and streamlined next generation sequencing (NGS) workflows for users of the AVITI System, an innovative sequencing and multi-omics platform based on Element’s novel avidity base chemistry.
- View the full release here: https://www.businesswire.com/news/home/20240205485948/en/
Launching today is a suite of high-quality adapters, universal blockers and library amplification primer mixes designed exclusively for the AVITI System.
- These products can support a wide range of applications, including DNA, RNA, and methylation sequencing workflows, as well as IDT’s proven hybridization capture chemistry.
- xGen Library Amplification Primer Mix for Element—premixed PCR primers, available in 16 or 96 reaction sizes, to increase yield for sequencing libraries post-hybridization capture.
ABC,
Tavarua,
SAN,
Workflow,
Multi,
RNA,
Science,
Research,
Agriculture,
DNA,
Mass meeting,
Gene,
Biomedicine,
Systems biology,
Informatics,
SVP,
UC,
Protein,
Computational biology,
HD,
Learning,
Biomedical engineering,
Cancer,
Endothelium,
Doctor of Philosophy,
Element,
Q50,
Leukemia Never before have so many data points been available to researchers at this cost and speed.
Key Points:
- Never before have so many data points been available to researchers at this cost and speed.
- Cloudbreak UltraQ is the industry's first commercial Q50 kit capable of generating 100-fold higher accuracy than currently available published specifications.
- Trinity is Element's on-board enrichment solution that simplifies targeted sequencing, to provide users with a new level of convenience, flexibility, and performance.
- AVITI24 streamlines these studies and data collection to enable rapid recursive learning with broad applications across systems biology.
Biology,
RNA,
Associate,
JPM,
Conference,
Science,
Protein,
Wellcome Sanger Institute,
Research,
Pathology,
CRISPR,
DNA,
Doctor of Philosophy,
SAN,
HD,
Stanford University,
Genetics,
Computational biology,
Trinity,
Genome,
Cell biology,
Q50,
Biological engineering,
Tavarua,
Pharmaceutical industry Achieving the fastest growth rate since launch among its peers, Element generated revenues in excess of $25 million in 2023.
Key Points:
- Achieving the fastest growth rate since launch among its peers, Element generated revenues in excess of $25 million in 2023.
- Element CEO and Co-founder Molly He presented on the following updates to AVITI at JPM:
Expert mode HD – Enhanced output options.
- An instrument option that allows users to generate 20 to 70 percent more reads per run from all sequencing kits.
- "When we launched AVITI in 2022 we redefined what is possible on a benchtop sequencer, offering an unprecedented combination of accuracy, speed, and cost.
